Newsroom Stories

A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS). The drug — based in part on research conducted at the School of Medicine — slows the progression of the deadly, paralyzing disease.

A new study led by the School of Medicine suggests that circadian rhythm — the natural cycle of physical and other changes our bodies go through in a 24-hour period — may affect the body’s response to the COVID-19 vaccine. The research suggests that vaccines given around the middle of the day may prevent more infections.

iHeard St. Louis, a program run by the Health Communication Research Laboratory at the Brown School, is expanding its  health misinformation response system to four new states plus Washington, D.C.

Sowande M. Mustakeem discusses her seminar “Medicine, Healing and Experimentation in the Contours of Black History” and the importance of grappling with traumatic history.

Washington University is partnering with the National Academies of Sciences, Engineering, and Medicine in its efforts to stimulate cultural change and support inclusive excellence in science and technology fields and is hosting a day of activities May 3 on the Danforth Campus.

The Olin-Brookings Commission — a partnership between WashU’s Olin Business School and the Brookings Institution supported by The Bellwether Foundation — presented evidence-based solutions to drive more equitable venture capital funding for women and underrepresented entrepreneurs to key stakeholders on Thursday, April 20, at the Brookings Institution.

Upon learning of the allegations published in The Free Press on February 9, we immediately launched a comprehensive and in-depth assessment of practices and care provided at the Washington University Transgender Center at St. Louis Children’s Hospital.

Four faculty members of Washington University in St. Louis were elected members of the American Academy of Arts & Sciences, the academy announced April 19. They are Jean Allman, Scott J. Hultgren, Tristram R. Kidder and Lilianna Solnica-Krezel.

Fuzhong Zhang, at the McKelvey School of Engineering, developed a method to create synthetic spider silk at high yields while retaining strength and toughness using mussel foot proteins.

An FDA-approved sleeping pill reduced levels of Alzheimer’s proteins in a small study of healthy volunteers led by School of Medicine researchers. The study hints at the potential of sleep medications to slow or stop Alzheimer’s progression, although much more research is needed regarding such an approach.